Table 6. Top eight rankings of the dose index affecting re-planning.
| Index | P1 | P2 | P3 | R |
|---|---|---|---|---|
| PTV Dmean | 0.89 | 0.08 | −0.29 | 0.89 |
| Rectal Dmax | 0.88 | −0.06 | 0.11 | 0.88 |
| PTV Dmax | 0.87 | 0.18 | −0.23 | 0.87 |
| Bladder Dmax | 0.85 | 0.18 | −0.20 | 0.85 |
| Bladder D2cc | 0.83 | 0.12 | −0.27 | 0.83 |
| Rectal D1cc | 0.83 | −0.07 | 0.09 | 0.83 |
| Rectal D2cc | 0.82 | −0.07 | 0.14 | 0.82 |
| Bladder D1cc | 0.81 | 0.16 | −0.23 | 0.81 |
Rule out other factors, only consider the effect of dose index on re-planning; that is, λ1=1; λ2=0; λ3=0, in which P1, P2, and P3 are the “dose index”, “tumor size index”, and “V30 index”, respectively. PTV, planning target volume.